Каталог · ЕАЭС
Клинические исследования и проекты
ACADIA Pharmaceuticals Inc. · найдено 3
3 исследования
Завершено
Фаза III
Россия
Pimavanserin tartrate (ACP-103)
A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson's Disease
Завершено
Фаза III
Россия
Pimavanserin; Placebo
Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (ACP-103-054/059)
Завершено
Фаза III
Россия